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Uropathogenic Escherichia coli (UPEC) is the primary cause of urinary tract infection (UTI) in 
the developed world. The major factors associated with virulence of UPEC are fimbrial adhesins, 
which mediate specific attachment to host receptors and trigger innate host responses. Another 
group of adhesins is represented by the autotransporter (AT) subgroup of proteins. The genome 
sequenced prototype UPEC strain CFT073 contains 11 putative AT-encoding genes. In this study 
we have performed a detailed molecular characterization of two closely related AT adhesins 
from CFT073: UpaB (c0426) and UpaC (c0478). PCR screening revealed that the upaB and 
upaC AT-encoding genes are common in E. coli. The upaB and upaC genes were cloned and 
characterized in a recombinant E. coli K-12 strain background. This revealed that they encode 
proteins located at the cell surface but possess different functional properties; UpaB mediates 
adherence to several ECM proteins while UpaC expression is associated with increased biofilm 
formation. In CFT073, upaB is expressed while upaC is transcriptionally repressed by the global 
regulator H-NS. In competitive colonization experiments employing the mouse UTI model, 
CFT073 significantly out-competed its upaB (but not upaC) isogenic mutant strain in the 
bladder. This attenuated phenotype was also observed in single challenge experiments, where 
deletion of the upaB gene in CFT073 significantly reduced early colonization of the bladder.  
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Urinary tract infections (UTIs) are among the most frequent human bacterial infections, with an 
estimated 40-50% of women experiencing at least one cystitis episode in their lifetime (19, 34). 
UTI usually starts as a bladder infection (cystitis), but can develop to acute kidney infection 
(pyelonephritis), ultimately resulting in scaring and renal failure. UTI is also a major cause of 
sepsis, which has a mortality rate of 25% and results in more than 36,000 deaths per year in the 
USA (66). Almost all patients with an indwelling urinary catheter for 30 days or longer develop 
catheter-associated UTI, which accounts for approximately 40% of all hospital-acquired 
infections (19). 
 
Uropathogenic Escherichia coli (UPEC) is the most common etiological agent responsible for 
UTI, resulting in more than 80% of infections. UPEC strains possess an array of virulence 
factors, with no factor solely responsible for the ability to cause UTI (49). However, the ability 
of UPEC to colonize the urinary tract and cause disease involves the expression of adhesins (e.g. 
type 1 and P fimbriae), toxins (e.g. hemolysin) and iron-acquisition systems that utilise 
siderophores (e.g. enterobactin, salmochelin, aerobactin) (36, 78). Adherence to the urinary tract 
epithelium enables bacteria to resist the hydrodynamic forces of urine flow, to trigger host and 
bacterial cell-signalling pathways and to establish infection. Among adhesins, P and type 1 
fimbriae correlate strongly with uropathogenesis and mediate binding to specific receptors within 
the urinary tract (11, 46, 53, 67, 79, 80). Both P- and type 1 fimbriae recognise their receptor 
targets by virtue of organelle tip-located adhesins, PapG and FimH, respectively (31, 38). Recent 
work employing a rat infection model has also demonstrated that P and type 1 fimbriae can act in 
synergy to establish an infection that leads to nephron obstruction within the kidneys (42). 
 
In addition to fimbrial adhesins, a number of autotransporter (AT) proteins associated with 
virulence have been characterized from UPEC. These include the secreted toxin Sat (21, 22), the 
phase variable outer membrane protein antigen 43 (Ag43) (69), the trimeric AT protein UpaG 
(72) and the surface-located UpaH (1). AT proteins represent the largest group of bacterial type 
V secreted proteins and share several common features: an N-terminal signal sequence, a 
passenger () domain that is either anchored to the cell surface or released into the external 
milieu, and a translocation () domain that resides in the outer membrane (27, 32). AT proteins 
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 were originally thought to possess structural properties that facilitate their independent transport 
across the bacterial membrane system and final routing to the cell surface (28). However, this 
classical view has recently been called into question, as accessory factors such as the Bam 
complex (also known as the YaeT or Omp85 complex), as well as periplasmic chaperones such 
as SurA, Skp and DegP, are required for the secretion of some AT proteins (30, 51, 56, 57, 59, 
74). In general, AT proteins differ substantially in their passenger domain sequence, which 
determines the unique functional characteristics of the protein and is often associated with 
virulence (28). 
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Eleven putative AT-encoding genes have been identified in the sequenced genome of the 
prototype UPEC strain CFT073 (1, 50). The biological significance of these AT proteins and 
their roles in UPEC pathogenesis remains to be fully elucidated. In this study, we have 
performed a detailed molecular characterization of two of these AIDA-I type conventional AT 
proteins, namely UpaB (c0426) and UpaC (c0478). The upaB and upaC genes were cloned and 
expression of UpaC significantly increased biofilm formation in a recombinant strain. Using 
Western blot analysis we showed that UpaB (but not UpaC) is expressed by CFT073. UpaC was 
shown to be transcriptionally repressed by the global regulator H-NS and mutation of the hns 
gene relieved this repression. In the mouse UTI model, deletion of upaB (but not upaC) in 
CFT073 significantly reduced early colonization of the bladder.  
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Bacterial strains and growth conditions. The strains and plasmids used in this study are listed 
in Table 1. Cells were routinely grown at 28oC or 37oC on solid or in liquid lysogeny broth (LB) 
medium (7) supplemented with the appropriate antibiotics, kanamycin (Kan, 50 µg/ml), 
chloramphenicol (Cam, 25 µg/ml), ampicillin (Amp, 100 µg/ml), spectinomycin (Spec, 50 
µg/ml), zeocin (Zeo, 50 µg/ml). For growth in defined conditions, M9 and M63B1 glucose media 
(58) were used as indicated. Bacterial cultures for mouse experiments were prepared by 
overnight growth in LB broth; all strains displayed an equivalent level of type 1 fimbriae 
expression as assessed by yeast cell agglutination. 
 
DNA manipulations and genetic techniques. DNA techniques were performed as described by 
Sambrook (58). Isolation of plasmid DNA was carried out using the QIAprep Spin Miniprep Kit 
(Qiagen). Restriction endonucleases were used according to the manufacturer's specifications 
(New England Biolabs). Chromosomal DNA purification was made using the DNeasy Blood and 
Tissue kit (Qiagen). Oligonucleotides were purchased from Sigma, Australia or France. All 
polymerase chain reactions requiring proofreading were performed with the Expand High 
Fidelity Polymerase System (Roche) as described by the manufacturer. Amplified products were 
sequenced to ensure fidelity of the PCR. DNA sequencing was performed using the ABI Big Dye 
ver3.1 Kit (ABI) by the Australian Equine Genetics Research Centre, University of Queensland, 
Brisbane. Prevalence studies for the upaB and upaC genes used Taq DNA polymerase, as 
described by the manufacturer (New England Biolabs), with the primers c0426.s-5 and c0426.s-3 
or c0478.s-5 and c0478.s-3 (Table S1). 
 
Construction of plasmids with AT-encoding genes. The upaB and upaC genes were amplified 
by PCR from UPEC CFT073 using specific primers designed from the available genome 
sequence. The following primers were used: upaB (c0426) (P1: 5’-
cgcgctcgagataataaggaatgggaaattgaaattagttac and P2: 5’-cggcgaagcttttaccaggtcacattgatac); upaC 
(c0478) (P3: 5’-cgcgctcgagataataaggatgacaaatgcactcctg and P4: 5’- 
cggcggaattcttaccaggtatatttaacac). PCR products containing upaB and upaC were digested with 
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 XhoI (forward primer) and HindIII/EcoRI (reverse primer) and ligated to XhoI-HindIII/EcoRI 
digested plasmid pBAD/Myc-HisA. The resultant plasmids were then digested with HindIII 
(upaB plasmid) or EcoRI (upaC plasmid) and ligated with a correspondingly digested 
kanamycin-resistance encoding gene cassette to give rise to plasmids pUpaB (pOMS14) and 
pUpaC (pOMS12). Resistance to kanamycin was required to facilitate transformation of these 
plasmids into the flu-negative, gfp-positive E. coli K-12 strain OS56. In all constructs, expression 
of the AT-encoding gene is under control of the arabinose-inducible araBAD promoter (23). 
Neither of the genes were cloned as fusions to the 6xHis-encoding sequence of the expression 
plasmid. Plasmids were verified by sequence analysis. The hns gene (c1701) was subcloned from 
pBAD30c1701 (37) via digestion with NheI/SphI and ligated to NheI/SphI digested pBR322, 
creating pH-NS. 
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Construction of deletion and over-expression mutants. In order to interrupt the AT-encoding 
genes in CFT073, create lacZ reporter transcriptional fusions, and place chromosomal target 
genes under the control of the RExBAD promoter or PcL promoter (13, 14, 55), we used 
homologous recombination mediated by λ-red recombinase expressed from the pKOBEG 
plasmid (15) and either a one step PCR procedure with 40-bp homology arms for recombination 
or a three-step PCR procedure with 500-bp homology arms for recombination (15) and 
http://www.pasteur.fr/recherche/unites/Ggb/matmet.html). The primers used to disrupt or insert 
the cassettes upstream of the genes used in this study are listed in Table S1. All mutants were 
confirmed via PCR and sequencing using primers Gene.ext 5’ and Gene.ext 3’, either as a primer 
set or individually in combination with internal primers designed to bind within the inserted 
DNA fragments. CFT073lacI-Z upaC::lacZ-zeo mutants were screened after mutagenesis with 
the suicide plasmid pSC189 carrying the kanamycin-resistant Mariner transposon described 
previously (10, 12). Sequencing out from the transposon in both directions enabled the site of 
insertion to be identified. 
 
Purification of 6xHistidine-tagged UpaB and UpaC truncated proteins, antibody 
production and immunoblotting. A 1219 bp segment from the passenger-encoding domain of 
upaB was amplified by PCR with primers UpaBTF (5’- tacttccaatccaatgccacggtatcaactgatccgg) 30 
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 and UpaBTR (5’- ttatgcacttccaatgttatgtggcttttagagtgctgtc) from E. coli CFT073 genomic DNA; 
underlined nucleotides represent the ligation-independent cloning (LIC) overhangs used for 
insertion into plasmid pMCSG7 via LIC cloning (16). The resultant plasmid (pUpaBTruncated) 
contained the base pairs 102-1320 of upaB fused to a 6xHis encoding sequence. E. coli BL21 
was transformed with plasmid pUpaBTruncated, induced with IPTG and the resultant 6xHis-
tagged UpaB truncated protein (containing amino acids 35-440 of UpaB) was assessed by SDS-
PAGE analysis as previously described (70). Polyclonal anti-UpaB serum was raised in rabbits 
by the Institute of Medical and Veterinary Sciences (South Australia). A polyclonal antibody 
raised against the enterohemorrhagic E. coli homologue of UpaC, EhaB cross reacted with UpaC 
and was used for UpaC detection (75). It is referred in our manuscript as anti-UpaC antiserum. 
For immunoblotting, whole-cell lysates were subjected to SDS-PAGE using NuPAGE
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® Novex® 
4-12% Bis-Tris precast gels with NuPAGE® MES running buffer and subsequently transferred to 
polyvinylidene difluoride (PVDF) microporous membrane filters using the iBlot™ dry blotting 
system as described by the manufacturer (Invitrogen). UpaB or UpaC antiserum, respectively, 
was used as primary serum and the secondary antibody was alkaline phosphatase-conjugated 
anti-rabbit IgG. Sigma FastTM BCIP/NBT was used as the substrate in the detection process. 
 
Biofilm assays. Biofilm formation on polystyrene surfaces was monitored by using 96-well 
microtitre plates (IWAKI) essentially as previously described (63). Briefly, cells were grown for 
24 h in LB (containing 0.2% arabinose for induction of AT-encoding genes) at 37oC, washed to 
remove unbound cells, and stained with crystal violet. Quantification of bound cells was 
performed by addition of acetone-ethanol (20:80) and measurement of the dissolved crystal 
violet at an optical density of 570 nm. Flow chamber experiments were performed as previously 
described (35, 62). Briefly, biofilms were allowed to form on glass surfaces in a multi-channel 
flow system that permitted on-line monitoring of their structural characteristics. Flow cells were 
inoculated with OD600 = 0.02 standardized cultures pre-grown overnight in M9 medium 
containing arabinose and kanamycin. Biofilm development was monitored by confocal scanning 
laser microscopy at 15 h post inoculation. For analysis of flow cell biofilms, z-stacks were 
analysed using COMSTAT software program (29). Microfermentor experiments were performed 
as previously described (5, 20). Briefly, overnight cultures were grown in M63B1+ 0.4% 
Glucose medium in the presence and absence of 0.2% arabinose at 37°C. Inoculation was 
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 performed by dipping the removable spatula in a culture containing 108 bacteria/ml for 2 min, 
followed by reintroduction of the spatula into the microfermentor. The M63B1+ 0.4% Glucose 
medium flow was set at the constant rate of 0.75 ml/min. After 24 h, the biofilm formed on the 
spatula was resuspended in 10 mL of PBS and the optical density at 600 nm was measured for 
each suspension; these values directly reflect the biofilm biomass. All experiments were 
performed in triplicate.  
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ECM Protein Binding assays. Bacterial binding to extra cellular matrix (ECM) proteins was 
performed in a microtiter plate ELISA assay essentially as previously described (72). Microtiter 
plates (Maxisorp; Nunc) were coated overnight at 4°C with MaxGel human extracellular matrix 
(10 ug/ml) or with 2 µg of the following ECM proteins, respectively; collagen (types I-V), 
fibronectin, fibrinogen, laminin, elastin, heparin sulfate, human serum album, BSA (Sigma-
Aldrich) or the glycoproteins N-acetyl-D-galactosamine (NaGal), N-acetyl-D-glucosamine 
(NaGlu) or N-acetylneuraminic acid (NaNa). Wells were washed twice with TBS (137mM NaCl, 
10mM Tris, pH 7.4) and then blocked with TBS-2% milk for 1 h. After being washed with TBS, 
200 µl of washed and standardised (OD600 = 0.1) MS427(pUpaB), MS427(pUpaC) or 
MS427(pBAD) was added and the plates were incubated at 37°C for 2 h. After being washed to 
remove non-adherent bacteria, adherent cells were fixed with 4% paraformaldehyde, washed, 
and incubated for 1 h with anti-E. coli serum (Meridian Life Sciences Inc., #B65001R) diluted 
1:500 in 0.05% TBS-Tween, 0.2% Milk, washed and incubated for 1 h with a secondary anti-
rabbit conjugated horseradish peroxidase antibody (diluted 1:1000) (Sigma-Aldrich; #A6154). 
After a final wash adhered bacteria were detected by adding 150 µL of 0.3mg/ml ABTS [2,2΄-
azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)] Sigma-Aldrich) in 0.1M citric acid pH 4.3, 
activated with 1 µl/ml 30% hydrogen peroxide] and the absorbance read at 405 nm. Mean 
absorbance readings were compared with negative control readings MS427(pBAD) using two-
sample t-tests within the Minitab V14 software package. P values < 0.05 were considered 
significant. 
 
Microscopy and image analysis. UpaB or UpaC antiserum was used for immunofluorescence 
microscopy and immunogold electron microscopy as previously described (68, 72). Microscopic 
observation of biofilms and image acquisition were performed on a scanning confocal laser 
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 microscope (LSM510 META, Zeiss) equipped with detectors and filters for monitoring of green 
fluorescent protein (Gfp). Vertical cross sections through the biofilms were visualised using the 
Zeiss LSM Image Examiner. Images were further processed for display by using Photoshop 
software (Adobe, Mountain View, Calif.). 
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β-galactosidase assays. β-galactosidase assays were performed essentially as previously 
described (43). Briefly, strains carrying lacZ fusions were grown on LB plates for 16 h then 
inoculated into LB medium. After 16-18 h of growth the culture was diluted in Z-buffer (60mM 
Na2HPO4, 40mM NaH2PO4, 50mM β-mercaptoethanol, 10mM KCl, 1mM MgSO4, pH 7), 
0.004% SDS and chloroform were added and the samples were vortexed to permeabilise the 
cells. Samples were incubated at 28oC and the reaction was initiated by the addition of ONPG. 
Reactions were stopped with the addition of sodium bicarbonate and the enzymatic activity was 
assayed in quadruplicate for each strain by measuring the absorbance at 420 nm. In some cases, 
β-galactosidase activity was also observed on LB agar plates containing 5-Bromo-4chloro-3-
indolyl-β-D-galactoside (X-gal). 
 
DNA curvature prediction and electrophoretic mobility shift assays. The upaC promoter 
region was analysed in silico using Bendit, a program that enables the prediction of a curvature-
propensity plot calculated with DNase I-based parameters (http://hydra.icgeb.trieste.it/dna/) (73). 
The curvature is calculated as a vector sum of dinucleotide geometries (roll, tilt and twist angles) 
and expressed as degrees per helical turn (10.5°/helical turn = 1°/bp). Experimentally tested 
curved motifs produce curvature values of 5–25°/helical turn, whereas straight motifs give values 
below 5°/helical turn. The upaC 250 bp promoter region was amplified using primers 
upaC.pro.ext-5+250 and upaC.pro.ext-3-1ATG and its intrinsic curvature assessed by comparing 
its electrophoretic mobility with that of an unbent marker fragment (Promega 100 bp DNA 
ladder) on a 0.5% TBE, 7.5% PAGE gel at 4°C for retarded gel electrophoretic mobility.  
 
Gel shift assays were performed essentially as previously described (3). A DNA mixture 
comprising an equimolar ratio of the PCR amplified upaC promoter region and TaqI-SspI 
digested pBR322 was incubated at room temperature for 15 minutes with increasing amounts of 
native purified H-NS protein (a gift from Dr S. Rimsky) in 30 μl of reaction mixture containing 
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 40 mM Hepes pH 8, 60 mM potassium glutamate, 8 mM magnesium aspartate, 5 mM 
dithiothreitol, 10% glycerol, 0.1% octylphenoxypolyethoxyethanol, 0.1 mg/ml-1 BSA (H-NS 
binding buffer). DNA fragments and DNA-protein complexes were resolved by gel 
electrophoresis (0.5% TBE, 3% MS agarose gel run at 50 V at 4°C) and visualised after staining 
with ethidium bromide. 
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Mouse model of UTI. Female C57BL/6 mice (8-10 weeks) were purchased from the University 
of Queensland Animal Facility and housed in sterile cages with ad libitum access to sterile water. 
The mouse model of UTI described previously was used for this study (54). Briefly, an inoculum 
of 20 µl, containing 5 x 108 CFU of bacteria in PBS (containing 0.1% India ink) was instilled 
directly into the bladder using a 1 ml tuberculin syringe attached to a catheter. Groups of mice 
were euthanized at 18 h and 5 days after challenge by cervical dislocation; bladders were then 
excised aseptically, weighed, and homogenized in PBS. Bladder homogenates were serially 
diluted in PBS and plated onto LB agar for colony counts. Competitive mixed infection assays 
were performed as described above except that mice were inoculated with a 50:50 mixture of 
CFT073amp and CFT073upaB or CFT073upaC grown in the absence of antibiotics. The two 
strains were differentiated by their resistance to ampicillin (CFT073amp) and zeocin 
(CFT073upaB) or kanamycin (CFT073upaC), respectively to enable differential colony counts 
of the recovered bacteria. The output ratios were normalized to the input ratios to determine the 
competitive index (competitive index [mutant ouput/wild-type ouput]/[mutant input/wild-type 
input]). For competitive infections, significance was determined using the Wilcoxon rank sum 
test on log10-transformed fitness indices against a hypothetical median of 0 (log101=0) using 
GraphPad Prism® 5. For single infections, median bacterial CFUs were compared using the 
nonparametric Mann-Whitney test within the Minitab V14 software package. P values < 0.05 
were considered significant. 
 
Statistical analysis. The prevalence of the upaB and upaC genes in uropathogenic and non-
pathogenic E. coli strains was compared using the Fisher's exact test. 
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Bioinformatic analysis of the UpaB and UpaC AT proteins from UPEC CFT073. Eleven 
putative AT-encoding genes have been identified in the sequenced genome of the prototype 
UPEC strain CFT073 (1, 50). In order to investigate the functionality of UpaB and UpaC we 
performed a bioinformatic analysis of these hypothetical proteins. Analysis of the 770 amino 
acid UpaB and the 995 amino acid UpaC sequence using the Conserved Domain Database 
(CDD) (40, 41) and the Simple Modular Architecture Design Tool (SMART) (39) identified a 
pertactin-like passenger domain (cl00185) followed by an AT β-domain (cl002365) in the C-
terminal region of both proteins. The predicted β-domain sequence begins at amino acid 500 for 
UpaB and amino acid 725 for UpaC. Further analysis with SignalP (6) identified a characteristic 
signal peptide for both proteins (31 amino acids in length for UpaB and 27 amino acids in length 
for UpaC). We also detected sequence similarity to the Pectin Lysase-like superfamily within the 
passenger (α) domain of UpaB and UpaC using InterProScan (82). The Pectin Lysase-like 
superfamily sequence has a predominant secondary structure of right-handed parallel β-helix 
topology.  
 
Prevalence of the AT-encoding genes in UPEC. The prevalence of the upaB and upaC genes 
was assessed by PCR screening of uropathogenic and non-pathogenic E. coli strains obtained 
from both the ECOR collection (48) and our own laboratory collection. The upaB and upaC 
genes are common amongst UPEC strains (58% (21/36) and 47% (17/36), respectively) and non-
pathogenic E. coli strains (42% (26/62) and 34% (21/62), respectively). There was no significant 
difference between the presence of the genes in UPEC and non-pathogenic E. coli. 
 
Cloning and expression of AT-encoding genes from UPEC CFT073. The upaB(c0426) and 
upaC(c0478) genes were PCR amplified and cloned as a transcriptional fusion downstream of 
the tightly regulated araBAD promoter in the pBAD/Myc-HisA expression vector to generate the 
plasmids pUpaB (pOMS14) and pUpaC (pOMS12), respectively. To demonstrate expression of 
the UpaB and UpaC proteins, plasmids pUpaB and pUpaC were transformed into the E. coli K-
12 flu mutant strains MS427 and OS56, respectively. E. coli MS427 contains a mutation in the 
Ag43-encoding flu gene and is unable to mediate cell aggregation and biofilm formation (52), 
 11
 while OS56 is a derivative of MS427 that has been tagged at the λ-attachment site with gfp (64). 
In the case of UpaB, Western blot analysis using a UpaB-specific antiserum resulted in the 
detection of a band corresponding to the full-length UpaB protein (80.1 kDa) in whole-cell 
lysates prepared from E. coli OS56(pUpaB) following induction with arabinose (Fig. 1A). 
Likewise, in the case of UpaC, Western blot analysis using a UpaC antiserum resulted in the 
detection of a band of 120 kDa (slightly larger than the predicted 107 kDa molecular mass of 
UpaC) in whole-cell lysates prepared from E. coli OS56(pUpaC) following induction with 
arabinose (Fig. 1A). No processing or cleavage of the respective mature passenger and 
translocation domain from UpaB or UpaC was observed in whole cell lysates or following brief 
heat treatment of the cells at 60ºC for 3 minutes (data not shown). 
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UpaB and UpaC are located at the bacterial cell surface. To examine if the UpaB and UpaC 
AT proteins were localized to the outer membrane immunofluorescence microscopy was 
performed (Fig. 1B). UpaB and UpaC antiserum readily reacted with E. coli MS427(pUpaB) and 
MS427(pUpaC), respectively, following induction with arabinose during growth in LB broth. 
Thus, UpaB and UpaC were effectively translocated to the cell surface. No reaction was seen 
with E. coli MS427(pBAD) cells. Surface localization of UpaB and UpaC was confirmed using 
immunogold labelling and electron microscopy (Fig. 1B). E. coli MS427(pUpaB) and 
MS427(pUpaC) cells clearly displayed surface labelling with gold particles following incubation 
with UpaB or UpaC antiserum compared to E. coli MS427(pBAD) cells. Thus, the upaB and 
upaC genes are functional and encode proteins located at the cell surface in E. coli. 
 
Phenotypic properties of UpaB and UpaC. AT proteins are frequently associated with 
aggregation, cell adherence, adhesion to ECM proteins and biofilm formation. The 
overexpression of UpaB and UpaC in E. coli OS56 did not result in aggregation or adherence to 
T24 epithelial cells, HeLa cells or shed human uroepithelial cells. However, when we assessed 
the ability to form a biofilm in a static non-treated polystyrene microtitre plate model UpaC, but 
not UpaB, promoted biofilm formation after growth in LB medium (t test P < 0.01) (Fig. 2A). 
Next, we tested the ability of the AT proteins to promote biofilm formation in dynamic 
conditions using the microfermentor and continuous flow chamber model systems, the latter 
allowing us to monitor bacterial distribution within an evolving biofilm at the single cell level 
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 due to the combination of gfp-tagged cells and scanning confocal laser microscopy. UpaC 
promoted significant biofilm growth in both the flow cell and microfermentor assays (unpaired t 
test with Welch´s correction P < 0.05) (Fig. 2B/C). Thus, UpaC represents a UPEC AT protein 
that promotes biofilm growth. 
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Next, we used an ELISA-based method to test the ability of UpaB and UpaC to mediate 
adherence to MaxGel, a commercially available mixture of ECM components including 
collagens, laminin, fibronectin, tenascin, elastin, a number of proteoglycans and 
glycosaminoglycans. UpaB (but not UpaC) promoted significant binding to MaxGel (Fig. 3), and 
this prompted us to examine binding in more detail by testing a range of different ECM proteins. 
UpaB promoted binding to fibronectin, fibrinogen and laminin but not to BSA (negative control) 
(Fig. 3) or to collagen type I, type II type III, type IV and type V, elastin, heparin sulfate, Human 
serum album or the glycoproteins N-acetyl-D-galactosamine (NaGal), N-acetyl-D-glucosamine 
(NaGlu) and N-acetylneuraminic acid (NaNa) (data not shown). Therefore, UpaB represents a 
UPEC AT protein that promotes specific binding to some ECM proteins. 
 
The UpaB protein is expressed by CFT073. To determine whether the UpaB and UpaC 
proteins are expressed by E. coli CFT073, we constructed isogenic deletion mutants of upaB and 
upaC, respectively, using λ-red mediated homologous recombination of linear DNA (these 
mutants are referred to as CFT073upaB and CFT073upaC, respectively). Examination of whole-
cell lysates prepared from these isogenic strains following growth in LB broth by Western 
blotting showed expression of UpaB (but not UpaC) in E. coli CFT073 (Fig. 4A). This was 
however not sufficient to allow detection of UpaB at the cell surface of CFT073 by 
immunofluorescence (Fig. 5A). Nevertheless, complementation of CFT073upaB with plasmid 
pUpaB restored the ability of this strain to produce detectable levels of UpaB at the cell surface 
(Fig. 5A). Western blot analysis did not show expression of UpaC from CFT073 (Fig. 4B). 
Accordingly, UpaC could not be detected at the cell surface of CFT073 by immunofluorescence 
(Fig. 5A). This was not caused by a defect in the stability of the protein as complementation of 
CFT073upaC with pUpaC resulted in detection of UpaC (Fig. 5B). In addition, we detected 
surface localization of both UpaB and UpaC in UpaB/UpaC over-expression strains constructed 
by chromosomal insertion of either the inducible RExBAD expression cassette or a λPR 
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 constitutive promoter (13, 55) in front of each open reading frame, respectively 
(CFT073RexBADupaB and CFT073RexBADupaC, CFT073PcLupaB and CFT073PcLupaC) 
(Fig. 5). 
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The H-NS protein is a repressor of UpaC. To investigate the genetic basis of repression of 
upaC, and compare this to upaB, we inserted a lacZ reporter as a transcriptional fusion to the 
promoters of upaB and upaC on the chromosome of CFT073lacI-Z to generate the strains 
CFT073lacI-Z upaB::lacZ-zeo and CFT073lacI-Z upaC::lacZ-zeo. When grown on X-gal plates 
all CFT073lacI-Z upaB::lacZ-zeo colonies were blue (indicating transcription) and all 
CFT073lacI-Z upaC::lacZ-zeo colonies were very faint blue (indicating very low levels of 
transcription). No colour heterogeneity was observed amongst the CFT073lacI-Z upaB::lacZ-zeo 
and CFT073lacI-Z upaC::lacZ-zeo colonies, indicating that expression of UpaB and UpaC is not 
subjected to phase variation.  
 
Subsequently, we created specific gene deletions by λ-Red mediated homologous recombination 
in a panel of defined/putative E. coli CFT073 regulatory genes: c0421 (virF_like), c1699 (rpoS), 
c1701 (hns), c2091 (virF_like), c2411 (hns_like), c3218 (stpA), c3244 (luxS AI-2), c3744 
(virF_like), c4864 (cpxR periplasmic stress), and c5054 (soxR Oxidative Stress) in CFT073lacI-Z 
upaB::lacZ-zeo and CFT073lacI-Z upaC::lacZ-zeo. Each of these mutants was then assayed for 
β-galactosidase activity to assess the effect of these regulators on transcription from the upaB or 
upaC promoter (data not shown). No regulators of upaB were identified (data not shown). 
However, H-NS was identified as a repressor of upaC; the CFT073lacI-Z upaC::lacZ-zeo hns 
mutant exhibited a 20-fold increase in β-galactosidase activity compared to CFT073lacI-Z 
upaC::lacZ-zeo (Fig. 4C). An independent experiment employing random mariner transposon 
mutagenesis resulted in the generation of six blue colonies, all of which possessed significantly 
increased β-galactosidase activity due to the inactivation of hns and thus confirmed these 
observations (data not shown). We also complemented the CFT073lacI-Z upaC::lacZ-zeo hns 
mutant with a hns-containing plasmid (pH-NS) and this resulted in a significant reduction in the 
expression of upaC (Fig. 4C). Thus, UpaC is repressed by H-NS. 
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 The H-NS protein represses upaC transcription in CFT073. To confirm the above mentioned 
results, a hns isogenic mutant was constructed in CFT073 and examined via Western blot 
analysis. Loss of H-NS from CFT073 resulted in the appearance of band representing UpaC, 
which migrated at the same size as UpaC from OS56(pUpaC) (Fig. 1A). However, no expression 
of UpaC was observed in a CFT073upaC hns double mutant (Fig. 4B). This H-NS specific 
repression of UpaC was not observed for UpaB, which was detected in wild-type CFT073 and a 
CFT073 hns mutant (Fig. 4A). Taken together, these results demonstrate that H-NS negatively 
regulates the expression of UpaC.  
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H-NS binds to the promoter region of upaC. H-NS binds to intrinsically curved regions of 
DNA. An in silico generated curvature-propensity plot calculated with DNase I-based parameters 
suggested that the promoter region of upaC may adopt a curved conformation (Fig. 4D). To 
experimentally demonstrate this curvature, a 250 bp PCR product containing the predicted upaC 
promoter region was generated and examined by polyacrylamide gel electrophoresis at 4°C. This 
method has been used previously to demonstrate DNA curvature (71, 81). Indeed, the 250 bp 
upaC promoter region displayed a slightly retarded gel electrophoretic mobility compared to 
non-curved DNA standards (Fig. 4E). In order to investigate whether H-NS influences gene 
expression by direct binding to the curved promoter region of upaC, we performed 
electrophoretic mobility shift assays. The 250 bp PCR product was mixed with TaqI-SspI-
digested pBR322 DNA (which contains the bla promoter and has been previously shown to be 
bound by H-NS) was incubated with increasing concentrations of purified H-NS protein and 
subsequently visualised by gel electrophoresis. The 250 bp upaC promoter region and the 
fragment containing the bla-promoter were retarded in mobility by the addition of 0.5µM H-NS 
(Fig. 4F). The pBR322 fragments not containing the bla-promoter were not influenced by H-NS 
at these concentrations, indicating that H-NS binds with specificity. These results suggest that H-
NS binds to the regulatory region of upaC by recognising a DNA region within 250 bp 5΄ of the 
ATG translation start codon. 
 
Deletion of upaB from CFT073 reduces colonization of the mouse bladder in a mixed 
infection competition assay. To assess the role of UpaB and UpaC on virulence we examined 
the ability of CFT073, CFT073upaB and CFT073upaC to survive in competitive-colonization 
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 experiments. The strains had an identical growth rate in LB broth and did not display any 
difference with respect to type 1 fimbriae production (as assessed by yeast cell agglutination and 
a fim switch orientation PCR) (data not shown). Mice were co-inoculated with CFT073 and 
CFT073upaB or CFT073 and CFT073upaC strains in a 1:1 ratio. In this assay, CFT073upaB was 
significantly out competed by CFT073 in the bladder of infected mice (P= 0.014) (Fig. 6A). No 
difference in colonization was observed between CFT073 and CFT073upaC (Fig. 6A). 
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Deletion of upaB from CFT073 reduces colonization of the mouse bladder in single 
infection experiments. To further assess the role of UpaB on virulence we examined the ability 
of CFT073 and CFT073upaB to survive in the mouse urinary tract in single infection 
experiments employing a short (1 day) and long (5 day) term protocol. We observed a significant 
reduction in colonization of the bladder by the CFT073upaB mutant (P<0.001; Fig. 6B) at day 
one post infection. However by day five post infection, equivalent bacterial loads were recovered 
for CFT073 and CFT073upaB (Fig. 6C). No significant colonization of the kidneys was observed 
for either strain; this is consistent with previous data from our laboratory using C57BL/6 mice 
(68, 72).  
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UPEC produce a range of fimbrial and non-fimbrial adhesins that play a role in virulence and 
contribute to persistent infection of the urinary tract. Some UPEC fimbrial adhesins, including 
type 1 and P fimbriae, have been well characterized with respect to their expression, regulation, 
receptor-binding target and role in virulence. Of the non-fimbrial adhesins, the AT family of 
proteins represents another group of virulence factors that contribute to adhesion, invasion and 
biofilm formation. Although UPEC possess multiple AT-encoding genes, very little is known 
about the function of their products and only Ag43, UpaG, Sat and UpaH have been associated 
with virulence (1, 21, 22, 69, 72). Here we characterize the UpaB and UpaC AT proteins from 
CFT073; we demonstrate that UpaB mediates binding to ECM proteins and contributes to early 
colonization of the mouse bladder while UpaC contributes to in vitro biofilm formation. 
 
Eleven putative AT-encoding genes have been identified in the sequenced genome of the 
prototype UPEC strain CFT073 (1, 50). In this study, we cloned and characterized the upaB and 
upaC AIDA-I type AT-encoding genes from CFT073. The upaB gene is present in all available 
UPEC genomes but absent or disrupted in all diarrhoeagenic E. coli genomes (77), suggesting it 
may contribute to UPEC virulence. The upaC gene is disrupted in the commensal E. coli strains 
MG1655, DH1 and HS. While there was no significant difference in the prevalence of the upaB 
and upaC genes in UPEC and non-pathogenic E. coli, our data suggests that their presence is 
associated with gene acquisition or loss mediated by mobile genetic elements. 
 
UpaB and UpaC both contain a predicted signal sequence, a pertactin-like domain and an AT β-
domain that is common to all AT proteins. The passenger domain possesses sequence similarity 
to the Pectin Lysase-like superfamily and contains extensive β-sheet secondary structure as 
predicted by the fold recognition program I-TASSER (83). It is therefore likely that the 
passenger domain of UpaB and UpaC comprises a β-helix structure akin to that proposed for the 
majority of other AT proteins (33). 
 
Several studies have demonstrated that the intimate cell-cell contact required for AT adhesin 
interaction can be physically blocked by the expression of larger surface structures such as 
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 fimbriae, flagella, LPS and the capsule (4, 26, 60, 61, 64, 68, 70). Our strategy to study the 
function of UpaB and UpaC involved the use of two host strains, MG1655flu and UPEC 
CFT073. The MG1655flu strain (and its Gfp+ derivative OS56) are well characterized and 
represent an ideal background to assess the function of AT adhesins (64). The surface expression 
of UpaC (but not UpaB) in this background significantly increased biofilm formation, while 
UpaB (but not UpaC) mediated adherence to several ECM proteins including fibronectin, 
fibrinogen and laminin. The lack of UpaC-mediated binding to laminin was in contrast to the 
previously reported binding characteristics of a closely related homologue, EhaB from EHEC 
(75). Although EhaB and UpaC share 62.1 % amino acid sequence identity and are detected with 
the same polyclonal EhaB anti-serum, the molecular basis for this difference in function remains 
to be elucidated. 
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Immunodetection of the UpaB and UpaC proteins revealed that while UpaB could be detected in 
whole cell extracts of CFT073, the UpaC protein was not detected in whole cell extracts of 
CFT073 prepared under the same conditions. The difference between the β-galactosidase activity 
measured from the upaB lacZ transcriptional fusion strain and the level of UpaB detected in 
CFT073 by western blot analysis may be due to mRNA stability or post-transcriptional factors 
that affect protein stability. H-NS is a histone-like DNA binding protein that represses multiple 
virulence factors in UPEC (45) and our results demonstrated that H-NS also acts as a repressor of 
upaC transcription, most likely through direct binding to its promoter region. H-NS was shown 
to bind to a region comprising the 250 bp upstream of the upaC open reading frame. Modulating 
the expression of the hns gene may well be a mechanism evolved by UPEC and other E. coli to 
control the expression of various virulence factors including adhesins. It is possible that the 
transcription of upaC is coordinated with other H-NS repressed genes; for example several 
cryptic E. coli chaperone-usher fimbrial genes were also recently shown to be repressed by H-NS 
(37). In contrast to upaC, targeted mutagenesis strategies did not indicate that the transcription of 
upaB is regulated by H-NS.  
 
While upaC expression was repressed in CFT073 during in vitro growth, analysis of the data 
deposited in the Array Express database examining the transcriptome of the asymptomatic 
urinary tract colonizer E. coli 83972 identified up-regulation of upaC transcription during 
 18
 biofilm formation in human urine (25), suggesting UpaC is expressed in conditions similar to 
those encountered in the urinary tract. Additionally, Hagan and Lloyd recently published the first 
transcriptome analysis for UPEC collected from the urine of patients with symptomatic UTI and 
compared this to the transcriptome of the same strains grown in vitro (24). Analysis of the data 
deposited in the GEO Series database revealed transcripts for upaB and upaC were detected in 
some UPEC strains, suggesting that these genes are transcribed during human UTI. We observed 
a significant difference in bladder colonization between CFT073 and CFT073upaB in a mixed 
competitive infection assay and at one day post infection in a single infection assay, strongly 
suggesting that expression of UpaB is associated with early colonization of the mouse bladder. In 
contrast, we did not observe any difference between CFT073 and CFT073upaB at 5 days post 
infection.  
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In the murine UTI model, UPEC colonization of the bladder is associated with the formation of 
intracellular bacterial communities (IBCs) within superficial umbrella cells (2). IBCs possess 
biofilm-like properties and are comprised of compact cell clusters encased in a polysaccharide 
matrix. IBC formation creates a quiescent state that may be associated with long-term persistence 
in the bladder (17, 47). Two phase variable cell-surface factors associated with biofilm 
formation, type 1 fimbriae and Ag43, are expressed by UPEC within IBCs (2). We did not 
observe any evidence of phase variable expression of UpaB or UpaC. However, given that UpaC 
promoted biofilm formation and UpaB promoted adherence to several ECM proteins, it is 
possible that both UpaB and UpaC contribute to this phenotype. 
 
A number of AT proteins have now been shown to contribute to UPEC virulence. Ag43, UpaB 
and UpaH contribute to colonization of the mouse bladder, albeit at different stages of infection. 
The UpaB and UpaG AT proteins mediate adherence to ECM proteins, while UpaG is also 
associated with adherence to bladder epithelial cells. In addition, the majority of these AT 
proteins are associated with biofilm formation, with Ag43 also contributing to IBC formation. 
The expression of these proteins may be coordinated with other larger surface structures such as 
the capsule, O antigen, flagella and fimbriae to mediate their affect on the ability of UPEC to 
colonize different niches. 
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FIG. 1. (A) Western blot analysis of UpaB and UpaC performed using whole-cell lysates 
prepared from E. coli grown in the presence of 0.2% arabinose (i) OS56(pUpaB), OS56(pBAD); 
(ii) OS56(pUpaC), OS56(pBAD); Lane M: Novex Sharp Molecular weight marker (B) Phase-
contrast (i), immunofluorescence (ii) and immunogold electron microscopy (iii) using UpaB-
specific antiserum against cells of E. coli strains MS427(pUpaB) and MS427(pBAD), or UpaC 
antiserum against cells of E. coli strains MS427(pUpaC) or MS427(pBAD). Cells were grown in 
the presence of 0.2% arabinose. Overnight cultures were fixed and incubated with anti-UpaB or 
anti-UpaC serum, respectively followed by incubation with goat anti-rabbit IgG coupled to Alexa 
Fluor 488 for immunofluorescence or protein A-gold (10 nm) conjugate. Gold particles were 
present on the surface of E. coli MS427(pUpaB) and MS427(pUpaC) but not the control strain 
MS427(pBAD). 
 
FIG. 2. Biofilm formation by E. coli OS56 cells harbouring plasmids expressing UpaB and 
UpaC. The effect of AT expression on biofilm formation was assessed in E. coli OS56 
(MG1655∆flu, Gfp+) cells containing the following plasmids pBAD, pUpaB, or pUpaC. All 
strains were grown in presence of 0.2% arabinose to induce AT protein expression. Three assays 
were used: (A) static biofilm formation in polystyrene microtitre plates, (B) dynamic biofilm 
formation in a microfermentor system, and (C) dynamic biofilm formation using a flow chamber 
model. In the dynamic-flow-chamber biofilm development was monitored by confocal scanning 
laser microscopy after 15 h. The images are representative horizontal sections collected within 
each biofilm and vertical sections (to the right of and above each larger panel, representing the yz 
plane and the xz plane, respectively) at the positions indicated by the red and green lines. E. coli 
MS427(pUpaC) produced a biofilm with a significant increase in total biovolume, substratum 
coverage and mean thickness compared to the vector control strain at 15 hr post inoculation 
(COMSTAT). In the microfermentor assay, UpaC also promoted significant biofilm growth 
compared to the vector control strain (unpaired t test with Welch´s correction P < 0.05).  
 
FIG. 3. UpaB mediates attachment to a range of ECM proteins in an ELISA-based binding 
assay. E. coli MS427(pUpaB) (black bars); E. coli MS427(pUpaC) (hatched bars); E. coli 
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 MS427(pBAD) (white bars). Results represent averages of 3 independent experiments + SEM. 
Mean absorbance readings were compared with negative control readings MS427(pBAD). 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
 
FIG. 4. The H-NS protein is a repressor of UpaC. (A) Western blot analysis of UpaB using 
whole cell lysates. (B) Western blot analysis of UpaC using whole cell lysates. (C) Beta-
galactosidase assay of upaB::lacZ-zeo and upaC::lacZ-zeo fusions. (D) Curvature-propensity 
plots showing predicted regions of curved DNA in the 250 bp upaC promoter. (E) Curved DNA 
PAGE gel of the amplified 250 bp upaC promoter at 4°C. Migration of this band is slightly 
retarded in the gel suggesting that the DNA is curved. (F) Electrophoretic band shift of the 
amplified 250 bp upaC promoter and the bla-promoter from digest pBR322 DNA. The pBR322 
fragments not containing the bla-promoter were not influenced by the increasing concentrations 
of (0.05, 0.1, 0.2, 0.5, 1 and 2 µM) H-NS. Images depict representative gels of at least two 
independent experiments 
 
FIG. 5. (A) Phase-contrast (i) or immunofluorescence (ii) microscopy employing UpaB-specific 
antiserum against cells of E. coli strains as specified. (B) Phase-contrast (i) or 
immunofluorescence (ii) microscopy using UpaC antiserum against cells of E. coli strains as 
specified. Strains were grown in the presence of 0.2% arabinose and labelled as induced where 
applicable. Overnight cultures were fixed and incubated with anti-UpaB or anti-UpaC serum 
followed by incubation with goat anti-rabbit IgG coupled to Alexa Fluor 488. A positive reaction 
indicating surface localization of UpaB or UpaC was detected only for the overexpressing 
strains. 
 
FIG. 6. Mouse UTI assays. (A) Competitive mixed infection experiment employing a 1:1 
mixture of E. coli CFT073amp / CFT073upaB and E. coli CFT073amp / CFT073upaC. Total CFUs 
were enumerated from the bladders of infected mice on selective medium to differentiate 
between E. coli CFT073amp / CFT073upaB and E. coli CFT073amp / CFT073upaC. Each symbol 
represents the Log10 fitness index calculated for each individual mouse and the median is 
represented by a horizontal line. A Log10 fitness index below 0 (shown by the dashed line) 
indicates that the upaB mutant is at a competitive disadvantage (P=0.014). (B and C) Single 
infection assay employing E. coli CFT073 and CFT073upaB. Data for individual mice are 
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 expressed as the Log10 of total CFU per 0.1 g of bladder tissue at day one (B) and day five (C) 
post infection. The number of mice used for each experiment (n) is indicated. The data represent 
a compilation of the results from two individual experiments. Medians are indicated by a solid 
line. E. coli CFT073 was recovered from the bladder of infected mice at day one post infection in 
significantly higher numbers than CFT073upaB (P<0.001). No statistical difference in the 
number of E. coli CFT073 and CFT073upaB was observed at day five post infection. 
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 Table 1. Bacterial strains and plasmids used in this study 1 
Strain or Plasmid Relevant characteristics Reference 
E. coli K12 strains   
MS427 MG1655flu  (52) 
OS56 MG1655flu  attB::bla-gfp Gfp+, AmpR (64) 
MS427(pBAD) MS427 pBADMycHisA, AmpR (76) 
MS427(pUpaC) pUpaC in MS427, AmpR  This study 
MS427(pUpaB) pUpaB in MS427,  AmpR This study 
OS56(pBAD) OS56 pBADMycHisA (76) 
OS56(pUpaC) pUpaC in OS56, AmpR KanR This study 
OS56(pUpaB) pUpaB in OS56,  AmpR KanR This study 
BL21 F- ompT hsdS(rB- mB-) dcm gal Stratagene 
MS2930 BL21 pUpaBTruncated This study 
S17-1pir 
 
RP4-2Tc::mu kan::Tn7 pir; Pir-
dependent replication, MuR KanR 
 
(65) 
S17-1pir_pSC189 pSC189 in S17-1pir,  AmpR KanR (12) 
E. coli CFT073 strains   
CFT073 wild-type UPEC isolate (44) 
CFT073ara CFT073 araDAB::zeo, ZeoR This study 
CFT073amp CFT073 attB::amp-cfp, AmpR (18) 
RExUpaB CFT073ara camRExBADupaB, ZeoR 
CamR, arabinose inducible UpaB 
This study 
RExUpaC CFT073ara specRExBADupaC, ZeoR 
SpecR, arabinose inducible UpaC 
This study 
CFT073upaB CFT073upaB::zeo, ZeoR This study 
CFT073upaC CFT073upaC::kan, KanR This study 
CFT073PcLupaB CFT073 kanPcLupaB, constitutively 
expressed UpaB, KanR 
This study 
CFT073PcLupaC CFT073 kanPcLupaC, constitutively 
expressed UpaC, KanR 
This study 
CFT073lacIZ CFT073lacIZ::cam, CamR This study 
CFT073lacIZ upaB::lacZ-zeo  CFT073lacIZ::cam upaB::lacZ-zeo, 
CamR ZeoR 
This study 
CFT073lacIZ upaB::lacZ-zeo c1701::kan CFT073lacIZ::cam upaB::lacZ-zeo 
c1701::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaB::lacZ-zeo c1701::kan pBR322 CFT073lacIZ::cam upaB::lacZ-zeo This study 
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 c1701::kan pBR322, CamR ZeoR KanR 
AmpR 
CFT073lacIZ upaB::lacZ-zeo c1701::kan pH-NS CFT073lacIZ::cam upaB::lacZ-zeo 
c1701::kan pH-NS, CamR ZeoR KanR 
AmpR 
This study 
CFT073lacIZ upaC::lacZ-zeo  CFT073lacIZ::cam upaC::lacZ-zeo, 
CamR ZeoR  
This study 
CFT073lacIZ upaC::lacZ-zeo c1701::kan CFT073lacIZ::cam upaC::lacZ-zeo 
c1701::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaC::lacZ-zeo c1701::kan pBR322 CFT073lacIZ::cam upaC::lacZ-zeo 
c1701::kan, CamR ZeoR KanR AmpR 
This study 
CFT073lacIZ upaC::lacZ-zeo c1701::kan pH-NS CFT073lacIZ::cam upaC::lacZ-zeo 
c1701::kan, CamR ZeoR KanR AmpR 
This study 
CFT073lacIZ upaB::lacZ-zeo c0421::kan CFT073lacIZ::cam upaB::lacZ-zeo 
c0421::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaC::lacZ-zeo c0421::kan CFT073lacIZ::cam upaC::lacZ-zeo 
c0421::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaB::lacZ-zeo c1699::kan CFT073lacIZ::cam upaB::lacZ-zeo 
c2291::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaC::lacZ-zeo c1699::kan CFT073lacIZ::cam upaC::lacZ-zeo 
c2291::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaB::lacZ-zeo c2091::kan CFT073lacIZ::cam upaB::lacZ-zeo 
c2291::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaC::lacZ-zeo c2091::kan CFT073lacIZ::cam upaC::lacZ-zeo 
c2291::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaB::lacZ-zeo c2411::kan CFT073lacIZ::cam upaB::lacZ-zeo 
c2411::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaC::lacZ-zeo c2411::kan CFT073lacIZ::cam upaC::lacZ-zeo 
c2411::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaB::lacZ-zeo c3218::kan CFT073lacIZ::cam upaB::lacZ-zeo 
c3218::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaC::lacZ-zeo c3218::kan CFT073lacIZ::cam upaC::lacZ-zeo 
c3218::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaB::lacZ-zeo c3244::kan CFT073lacIZ::cam upaB::lacZ-zeo 
c4244::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaC::lacZ-zeo c3244::kan CFT073lacIZ::cam upaC::lacZ-zeo 
c4244::kan, CamR ZeoR KanR 
This study 
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 CFT073lacIZ upaB::lacZ-zeo c3744::kan CFT073lacIZ::cam upaB::lacZ-zeo 
c3744::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaC::lacZ-zeo c3744::kan CFT073lacIZ::cam upaC::lacZ-zeo 
c3744::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaB::lacZ-zeo c4864::kan CFT073lacIZ::cam upaB::lacZ-zeo 
c5054::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaC::lacZ-zeo c4864::kan CFT073lacIZ::cam upaC::lacZ-zeo 
c5054::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaB::lacZ-zeo c5054::kan CFT073lacIZ::cam upaB::lacZ-zeo 
c5054::kan, CamR ZeoR KanR 
This study 
CFT073lacIZ upaC::lacZ-zeo c5054::kan CFT073lacIZ::cam upaC::lacZ-zeo 
c5054::kan, CamR ZeoR KanR 
This study 
   
Plasmids   
pUpaB 
(pOMS14) 
upaB gene (c0426) from CFT073 in 
pBAD/Myc-HisA-kan, AmpR KanR 
This study 
pUpaC 
(pOMS12) 
upaC gene (c0478) from CFT073 in 
pBAD/Myc-HisA-kan, AmpR KanR 
This study 
pBAD30c1701 H-NS c1701 (H-NS) from CFT073 in 
pBAD30, AmpR 
(37) 
pBR322 AmpR TetR (8) 
pH-NS pBR322 c1701 (H-NS) from CFT073, 
AmpR 
This study 
pKOBEG pSC101 ts (replicates at 30°C), araC, 
arabinose-inducible λredγβα operon , 
CamR  
(9) 
pSC189 oriT, -dependent oriR6K, mariner-
based transposon TnSC189, AmpR 
KanR  
(10) 
 1 
2 
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